Utility of Bronchoscopy in Patients With Haemoptysis and Negative Chest CT Scan (ULYSSES)
Recruiting
Observational Study
Hemoptysis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 150 (estimated)
- Sponsor
- University of Milan · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Conflicting evidence exist in the literature on the utility of bronchoscopy in patients with haemoptysis and negative/non-diagnostic chest CT scan.
The primary aim of this prospective, observational, multicenter study is to evaluate the utility of bronchoscopy in patients with haemoptysis and negative/non-diagnostic CT scans. Secondary aims are related to the utility of bronchoscopy to detect occ…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* ≥18 years old
* Haemoptysis of unknown origin
* Negative or non-diagnostic chest CT scan
Exclusion Criteria:
* Known bleeding lesions of the upper or lower respiratory airways
* Chest CT scan diagnostic for hemoptysis etiology
* Refusal to sign the informed consent
* Refusal…
Contacts
Michele Mondoni, MD
0039 0281843025
michele.mondoni@asst-santipaolocarlo.it; michele.mondoni@unimi.it
CONTACT